Groowe Groowe / Newsroom / ABBV
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ABBV News

ABBVIE INC.

Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors

globenewswire.com
ABBV IGIC

BIMZELX® (bimekizumab-bkzx) demonstrates superior efficacy over SKYRIZI® (risankizumab-rzaa) in psoriatic arthritis: BE BOLD Week 16 data

prnewswire.com
ABBV UCB

Sotyktu’s Psoriatic Arthritis Launch Builds Gradually in Month Two as Rheumatologists Continue to Take Measured Approach to TYK2 Adoption, According to Spherix Global Insights

globenewswire.com
BMY ABBV UCB ALMS PFE

Polymyositis Market Research Report 2026-2036: Competitive Landscape is Dominated by Major Players Such As Teva Pharmaceuticals, Gilead Sciences, Roche, AbbVie, and Pfizer

globenewswire.com
TEVA GILD ABBV PFE

Caliway Makes First ECO 2026 Oral Presentation on Preclinical Data of CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies, Attracting Strong Interest from International Experts and Global Pharmaceutical Companies for Its Systemic Metabolic

prnewswire.com
ABBV AZN BMY LLY NVO

Kernicterus Market Research and Forecast Report 2026-2036 Featuring Pfizer, F.Hoffmann La Roche,. Merck, AbbVie, AsteraZeneca, Abbott Laboratories, Sanofi, GlaxoSmithKline, Grifols

globenewswire.com
PFE ABBV AMGN ABT GILD

Global Radiopharmaceuticals Market Set for Significant Expansion at a CAGR of ~10% by 2034 with Increasing Adoption of Targeted Radiotherapy | DelveInsight

prnewswire.com
LH TH GEHC EL AZN AMGN PFE MRK BMY REGN GILD ABBV SNY XRAY BRKR

Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth

globenewswire.com
ABBV ACB BHC CGC

Form 8-K

sec.gov
ENVB ABBV

Facial Injectables Market to Surge From USD 15.64 Billion in 2026 to USD 29.94 Billion by 2036, Driven by Hyaluronic Acid Fillers and Botulinum Toxin Treatments

accessnewswire.com
ABBV RVMD